Landfar Bio-medicine Co., Ltd (SZSE: 000504)
Health Care · Biotechnology · CN
CN¥11.79
-5.07% today · +32.3% 1Y
Landfar Bio-medicine Co., Ltd (SZSE: 000504) operates in the Biotechnology industry within the Health Care sector. The company is valued at $580.91M and employs 316 people.
Over the last twelve months the share price has gained 32.3%, trading between 7.02 and 14.04.
Tweenvest scores Landfar Bio-medicine Co., Ltd across four factors: quality 61/100, value 51/100, growth 100/100. Its strongest factor is growth.
000504 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $580.91M
- Revenue (TTM)
- $97.20M
- P/E
- 98.68
- EPS
- 0.12
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- CN¥14.04
- 52-week low
- CN¥7.02
- Avg volume (3M)
- —
- Shares outstanding
- 330.02M
- Employees
- 316
- Next earnings
- —
About Landfar Bio-medicine Co., Ltd
Landfar Bio-medicine Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It also involves in the storage of biological resources, stem cells and immune cells. The company was founded in November 1988 and is headquartered in Changsha, China.
- ISIN
- CNE000000263
- Founded
- 1991
- Listed since
- Dec 8, 1992
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Berry Genomics Co.,LtdSZSE: 000710 | $596.41M | CN¥11.30 | +3.96% |
| Silence Therapeutics plcNasdaqGM: SLN | $593.66M | $9.65 | -2.13% |
| Medicalsystem Biotechnology Co., LtdSZSE: 300439 | $591.56M | CN¥10.31 | +0.59% |
| Blau Farmacêutica S.A.BOVESPA: BLAU3 | $584.71M | R$12.61 | +16.54% |
| Guangdong Hybribio Biotech Co.,Ltd.SZSE: 300639 | $575.67M | CN¥6.14 | -2.07% |
| Pharmicell Co., Ltd.KOSE: A005690 | $573.98M | ₩12,860.00 | +3.71% |
| Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163 | $563.39M | CN¥34.87 | -12.83% |
| Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373 | $561.38M | CN¥5.73 | -0.87% |
Figures last refreshed Oct 11, 2026.